Administrative Core
行政核心
基本信息
- 批准号:10900843
- 负责人:
- 金额:$ 50.3万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-04-04 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdministratorAffectAreaAtlasesAwardBackBenchmarkingBiological AssayBiological Specimen BanksBudgetsClinicalCollectionCommunicationCommunication ToolsCompetenceComplexComputer softwareConsultationsCore FacilityCutaneousDataData AnalysesData CollectionData Coordinating CenterData Storage and RetrievalDiseaseElectronic MailEmerging TechnologiesEnsureEuropeanEvaluationFacultyFundingGoalsHematologyHomeHumanImageImaging technologyIncubatorsInfrastructureInstitutionLaboratoriesMeasuresMediationMedicalMethodsParticipantPathologistPharmacologyProcessProtocols documentationPublishingQuality ControlReagentResearchResearch PersonnelResolutionResourcesRunningScheduleScientistSoftware EngineeringSynapsesSystemTechnologyTechnology AssessmentTrainingUnited States National Institutes of HealthUniversitiesValidationWorkcohortdata analysis pipelinedata pipelinedata repositoryexperienceimprovedindexinginter-institutionalinterestmedical schoolsmeetingsmembernew technologyoperationpremalignantprogramsprospectivequality assurancesoftware developmenttechnology developmenttooltumor
项目摘要
ADMINISTRATIVE CORE – SUMMARY ABSTRACT
The Center for Pre-cancer Atlases of Cutaneous and Hematologic Origin (PATCH Center) will construct
two pre-cancer atlases (PCAs) by combining the expertise of investigators from multiple institutions in the
Longwood Medical Area (LMA), Harvard University and the Broad Institute. By leveraging the expertise and
resources of the Laboratory of Systems Pharmacology (LSP) at Harvard Medical School, where the majority of
PATCH Center operations will be co-located, the Administrative Core will ensure bi-directional exchange of
findings and resources with other PCA/HCAs and with participants in the Human Tumor Atlas Network. The
Administrative Core will be responsible for providing logistical and organizational support for Center activities,
for coordinating workflows across institutions and for interaction with the Human Tumor Atlas Network (HTAN).
Working closely with the HTAN Data Coordinating Center (HTAN-DCC) and the NCI, the Administrative Core
will ensure that data, tools and protocols are collected and shared following standards set by the HTAN
Steering Committee.
Aim 1 will establish an Executive Committee to lead the PATCH Center and its functional units
(Biospecimen, Characterization and Data Analysis) and three subcommittees: (i) a Quality Control and
Assurance (QA) Subcommittee will be responsible for implementing QA/QC processes and compliance with
SOPs (ii) a Milestone and Benchmark (MB) Subcommittee will be responsible for ensuring timely completion of
milestones and benchmarks and for addressing any problems that arise (iii) a Technology Development and
Evaluation (TD) Subcommittee will be responsible for evaluating new and emerging technologies,
troubleshooting problems with existing technologies, and working closely with other members of the HTAN on
technology assessment, improvement and integration. Pathologist Sandro Santagata will serve as quality
assurance officer and apply his experience in CLIA laboratory operations to competency and proficiency
training across the Center. Aim 2 will develop and maintain effective communication strategies within the
PATCH Center and between HTAN centers through regular meetings and using electronic communication
tools such as Slack and Trello; and will ensure timely release of Atlas data and transfer to the HTAN-DCC via
an API. Aim 3 will perform regular evaluation of overall and interim center milestones and take corrective
action when required, including communicating to the NCI any problems likely to affect overall progress in
Atlas construction and release.
行政核心——摘要摘要
皮肤和血液起源癌前图谱中心(PATCH中心)将建设
两个癌前图谱(PCA),结合了来自多个机构的研究人员的专业知识
朗伍德医学区 (LMA)、哈佛大学和布罗德研究所利用专业知识和技术。
哈佛医学院系统药理学实验室 (LSP) 的资源,其中大多数
PATCH 中心运营将位于同一地点,管理核心将确保双向交换
与其他 PCA/HCA 以及人类肿瘤图谱网络参与者的研究结果和资源。
行政核心将负责为中心活动提供后勤和组织支持,
用于协调跨机构的工作流程以及与人类肿瘤图谱网络 (HTAN) 的交互。
与 HTAN 数据协调中心 (HTAN-DCC) 和管理核心 NCI 密切合作
将确保按照 HTAN 制定的标准收集和共享数据、工具和协议
指导委员会。
目标1将设立执行委员会来领导PATCH中心及其职能单位
(生物样本、表征和数据分析)和三个小组委员会:(i) 质量控制和
保证 (QA) 小组委员会将负责实施 QA/QC 流程并遵守
SOP (ii) 里程碑和基准 (MB) 小组委员会将负责确保及时完成
里程碑和基准以及解决出现的任何问题 (iii) 技术开发和
评估(TD)小组委员会将负责评估新兴技术,
使用现有技术解决问题,并与 HTAN 的其他成员密切合作
病理学家 Sandro Santagata 将担任质量评估、改进和整合工作。
保证官并将其在 CLIA 实验室运营方面的经验应用于能力和熟练程度
整个中心的培训目标 2 将在中心内制定和维持有效的沟通策略。
PATCH 中心和 HTAN 中心之间通过定期会议并使用电子通信
Slack和Trello等工具;并将确保Atlas数据及时发布并通过HTAN-DCC传输
API 将对总体和临时中心里程碑进行定期评估并采取纠正措施。
必要时采取行动,包括向 NCI 传达任何可能影响总体进展的问题
Atlas 构建和发布。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PETER Karl SORGER其他文献
PETER Karl SORGER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PETER Karl SORGER', 18)}}的其他基金
Pre-cancer atlases of cutaneous and hematologic origin (PATCH Center)
皮肤和血液来源的癌前图谱(PATCH 中心)
- 批准号:
10818803 - 财政年份:2023
- 资助金额:
$ 50.3万 - 项目类别:
Systems Pharmacology of Therapeutic and Adverse Responses to ImmuneCheckpoint and Small Molecule Drugs
免疫检查点和小分子药物治疗和不良反应的系统药理学
- 批准号:
10405812 - 财政年份:2021
- 资助金额:
$ 50.3万 - 项目类别:
Systems Pharmacology of Therapeutic and Adverse Responses to ImmuneCheckpoint and Small Molecule Drugs
免疫检查点和小分子药物治疗和不良反应的系统药理学
- 批准号:
10343835 - 财政年份:2018
- 资助金额:
$ 50.3万 - 项目类别:
Project 1: Multi-scale modeling of adaptive drug resistance in BRAF-mutant melanoma
项目 1:BRAF 突变黑色素瘤适应性耐药的多尺度建模
- 批准号:
10343839 - 财政年份:2018
- 资助金额:
$ 50.3万 - 项目类别:
Systems Pharmacology of Therapeutic and Adverse Responses to ImmuneCheckpoint and Small Molecule Drugs
免疫检查点和小分子药物治疗和不良反应的系统药理学
- 批准号:
9886211 - 财政年份:2018
- 资助金额:
$ 50.3万 - 项目类别:
Pharmaco Response Signatures and Disease Mechanism
药物反应特征和疾病机制
- 批准号:
8926239 - 财政年份:2014
- 资助金额:
$ 50.3万 - 项目类别:
相似海外基金
School-Partnered Collaborative Care (SPACE) for Pediatric Type 1 Diabetes
针对儿童 1 型糖尿病的学校合作协作护理 (SPACE)
- 批准号:
10640614 - 财政年份:2023
- 资助金额:
$ 50.3万 - 项目类别:
Learning and Living with Wildfire Smoke: Creating Clean Air Environments in Schools through Youth Participatory Action Research
与野火烟雾一起学习和生活:通过青年参与行动研究在学校创造清洁的空气环境
- 批准号:
10662674 - 财政年份:2023
- 资助金额:
$ 50.3万 - 项目类别:
Addressing Dental and Psychiatric Comorbidities: Screening and Referrals of HIV/AIDS Patients
解决牙科和精神合并症:艾滋病毒/艾滋病患者的筛查和转诊
- 批准号:
10671164 - 财政年份:2023
- 资助金额:
$ 50.3万 - 项目类别:
Understanding the relationship between nurse staffing and outcomes: impact of individual nurse education, expertise, and effort level on individual patient outcomes
了解护士人员配置与结果之间的关系:护士个体教育、专业知识和努力水平对个体患者结果的影响
- 批准号:
10642570 - 财政年份:2023
- 资助金额:
$ 50.3万 - 项目类别: